ScrutarSign up free

ACCURAY INC (ARAY)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CareHealth Care Equipment & Supplies

Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions intended to help clinical teams deliver precise radiation treatments across a broad range of cases, from curative to palliative care. Its systems are designed to support treatments such as SRS, SBRT, IMRT, IGRT and adaptive radiation therapy, with software-enabled motion management, image guidance and tools for adaptive workflows and retreatment planning. The company was incorporated in California in 1990, began operations in 1992 and reincorporated in Delaware in 2007.

The portfolio has two platform families. The robotic CyberKnife platform, whose latest generation is the CyberKnife S7 System, mounts a compact X-band linear accelerator on a robotic arm. It uses Synchrony real-time target tracking and the Accuray Precision Treatment Planning System with VOLO Optimizer. It is offered with fixed, Iris variable aperture and InCise multi-leaf collimators, and the CyberKnife S7 F configuration is aimed at neuro-radiosurgery, working with Brainlab Elements software. The helical portfolio builds on TomoTherapy and includes Accuray Stellar for adaptive radiotherapy, the Radixact System as a flexible tailored solution, Accuray Helix as an entry point into helical therapy, and the Tomo C System, a made-in-China system from the CNNC-Accuray joint venture. Helical systems use a ring gantry with a 64-leaf binary MLC, TomoHelical and TomoDirect delivery modes, and ClearRT helical kVCT imaging on selected configurations. Accuray also provides customer support, installation, training and other professional services. It is expanding into remote diagnostics, workflow optimization, analytics and clinical support, and is developing AI-enabled predictive maintenance and diagnostic tools.

Customers are clinical teams, including radiation oncologists and neurosurgeons, in hospitals and cancer centers. The CyberKnife is used for tumors throughout the body, including the brain and spine, and for selected neurologic and endocrine disorders. Outside the United States, Accuray has regional offices in Morges, Switzerland; Hong Kong; Shanghai; and Tokyo. It has direct sales staff in most of Western Europe, Japan, India, Korea and Canada, and distributors across Europe, the Middle East, Africa, Asia Pacific and Latin America. The joint venture manufactures and sells radiation oncology systems in China.

Its strategy centers on greater physician adoption, international expansion, portfolio differentiation, recurring service revenue and operating efficiency, including supply chain optimization and selective outsourcing. Partnerships include RaySearch Laboratories (RayStation and RayCare integration), Photo Diagnostic Systems, Brainlab, GE Healthcare, Airbus and IUCT-Oncopole, TrueNorth Medical Physics, and a 10-year collaboration with the University of Wisconsin School of Medicine and Public Health. The principal U.S. office is in Madison, Wisconsin.

AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.

RevenueFY2026
$401.95M
▼ 12.3%YoY
Net incomeFY2026
-$49.19M
▼ 2992.0%YoY
Gross margin
27.7%
▼ 432 bpsYoY
Insider net6 mo
+248.9K
shares0 sells0 buys
Institutions
36
$8.5M held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
-$200M$200M$400M$600M
FY2023FY2024FY2025FY2026
RevenueNet income
FY2026 highlightsfrom 10-K
Gross profit$111.45M
Operating income-$26.44M
Gross margin27.7%
Net margin-12.2%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
10-QNov 6, 2026EDGAR
8-KNov 4, 2026EDGAR
8-KNov 4, 2026EDGAR
4La Neve Stephen R.Nov 2, 2026EDGAR
4MURPHY MICHAEL JOHNNov 2, 2026EDGAR
DEF 14AOct 17, 2026EDGAR
8-KOct 14, 2026EDGAR
8-KOct 7, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
La Neve Stephen R.Oct 31, 2026Tax withholding
La Neve Stephen R.Oct 31, 2026Option exercise
MURPHY MICHAEL JOHNOct 31, 2026Tax withholding
MURPHY MICHAEL JOHNOct 31, 2026Option exercise
Pervaiz AliSep 23, 2026Tax withholding

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
Neuberger Berman Group LLC5.1%Oct 27, 2026$1.57M
Vanguard Capital Management3.7%Aug 13, 2026$1.14M
BlackRock, Inc.2.7%Aug 7, 2026$842K
AQR CAPITAL MANAGEMENT LLC2.3%Aug 14, 2026$701K
JANE STREET GROUP, LLC1.8%Aug 14, 2026$554.7K

ARAY's filings are public. The insight is one click away.

Scrutar's AI reads every ARAY filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze ARAY filingsNo credit cardAI reports included on the free plan

Never miss a ARAY filing.

Get an email when ARAY files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Nov 8, 2026Source: SEC EDGAR.